SPPH 513 EBM news and readings

Things to read that get you thinking while you do SPPH 513

Archive for the ‘Comparative effectiveness research’ Category

The most beautiful place on earth … will have the least chronic disease on earth … if only …

Posted by rbrands on March 8, 2010

As outlined in the Vancouver Sun, Health Minister Kevin Falcon came across a striking finding reading a British newspaper last summer. He read that “people who take regular exercise, stay slim, eat a healthy diet and never smoke reduce their chances of developing chronic disease by almost 80 percent.” Thinking about this, he realized that “this issue of health promotion has to go far beyond just printing brochures and telling people they ought to live a healthier life.” Going on, he says “I think we have to figure out how we can be much more aggressive in pushing that kind of a health promotion onto British Columbians.”

Canadians tend to smile at American exceptionalism. These are difficult questions that no society, seemingly, has figured out up to now. Thankfully our Ministry of Health is onto this, and our province will lead the world to a solution, albeit aggressively. Hopefully this won’t involve Tasering people who actively resist the aggression that’s for their own good.

Posted in Comparative effectiveness research | Tagged: | Comments Off

“It’s devastating … no going back to normal.”

Posted by rbrands on March 6, 2010

Friday’s Globe and Mail had an article about women with breast cancer. These women were/are given a choice of four cycles of Taxotere, or twelve cycles of Taxol for their cancer. The efficacy of these two alternatives is about the same (apparently).

Taxol, the cheaper generic, has “a very tiny risk of permanent hair loss.” Taxotere has a 3 in 100 chance of permanent hair loss (alopecia universalis). This means permanent loss of all body hair (eyebrows, everything). Another study puts this likelihood as high as 6 in 100.

Most women, when given a choice, choose Taxol.

The company’s (Sanofi) response to this is: “We fully understand that persistent alopecia may be a burden for patients, but still we consider it’s certainly something which is not life-threatening or is not something which impairs the likelihood of survival.” In other words, “we saved your life, so there.”

Sounds  like a case of POEM, and a situation where values enter the equation. CDA anyone?

Posted in Comparative effectiveness research, Therapy | Tagged: , | Comments Off

 
Follow

Get every new post delivered to your Inbox.